ALHC
Alignment Healthcare, Inc.
NASDAQ · Healthcare · Medical - Healthcare Plans · US
$13.54
−0.04%Aug 25, 2026, 23:45 UTC
Kaplan Fox & Kilsheimer LLP announced an investigation into potential securities violations by Alignment Healthcare, Inc. following a whistleblower complaint alleging accounting irregularities.
Source:Aug 11, 2026, 08:10 UTC
Alignment Healthcare CEO John Kao sold 298,000 shares of the company's stock on August 10, 2026, at an average price of $13.88, totaling approximately $4.14 million.
Source:Aug 3, 2026, 11:00 UTC
Kaplan Fox & Kilsheimer LLP announced it is investigating potential securities violations by Alignment Healthcare, Inc. and encourages investors who suffered losses to contact the firm.
Jul 30, 2026, 20:01 UTC
Alignment Healthcare reported financial results for the second quarter of 2026, surpassing the high end of guidance across all key metrics.
Jul 28, 2026, 16:55 UTC
Hagens Berman launched an investigation into Alignment Healthcare for potential securities law violations after a whistleblower lawsuit alleged financial manipulation.
Source:Jul 9, 2026, 01:20 UTC
A former Alignment Healthcare executive filed a whistleblower lawsuit alleging the company engaged in deliberate accounting irregularities to inflate its financial results.